Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer
Launched by UNIVERSITY OF AARHUS · Dec 8, 2017
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
Background: Colorectal cancer (CRC) is among the most frequent types of cancer in Denmark with 5,015 incident cases in 2015 (3,455 colon cancer and 1,560 rectal cancer), and an average annual number of deaths of 1900 persons in the period 2010-2014. Around 20% of patients are diagnosed in the most advanced stage of disease, contributing to high mortality, as an advanced stage of cancer is associated with a poor prognosis.
The Danish cancer patient pathway for CRC was implemented in 2008 with the aim of assuring fast and efficient diagnosing and treatment of cancer patients. In accordance w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Referred by a GP in the Central Denmark Region to colonoscopy in the cancer patient pathway for colorectal cancer.
- Exclusion Criteria:
- • Referred to colonoscopy in the cancer patient pathway due to non-alarm symptoms.
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Horsens, , Denmark
Patients applied
Trial Officials
Cathrine Nielsen, PhD
Principal Investigator
University of Aarhus
Peter Vedsted, Professor
Study Director
University of Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials